DRG uses cookies to improve your experience on this website. Some of the cookies we use are essential for parts of the website to operate. Please be aware that if you continue without changing your cookie settings, you consent to this. For more information on our use of cookies, please review our cookie policy.

Research & Reports

Searching in Market Access (2718)

Boston | Massachusetts | 2019 | Market Overview (Event Driven)

Boston | Massachusetts | 2019 | Market Overview (Event Driven)

Thank you!

Your request has been received by DRG. A represantative will contact you shortly to provide more details on the research and data contained in this report and ensure that it will meet your current research needs.

The Boston market boasts a healthy population and some of the highest-quality care in the nation, but it also features lofty prices and above average hospital use. Payment reform initiatives are well-established, but prestigious health systems continue to demand very high reimbursements. Reimbursement disparity has compromised the sustainability of smaller community hospitals and drives consolidation. Blue Cross Blue Shield of Massachusetts continues to lead in payment reform by expanding value-based contracts to cover hospital services and care for PPO members. Although they are a primary driver of cost growth, drug prices are largely exempt from the state’s famously rigorous oversight. Health systems have responded by creating and expanding their own specialty pharmacies. Expect momentum to build around proposals that would force drug companies to provide more price transparency.

  • Pub Date: April 2019

Purchase Report

Recent reports:
You may also be interested in: